Literature DB >> 11866313

Mucosal IgA defect in primary biliary cirrhosis.

Annarosa Floreani, Anna Baragiotta, Daniela Pizzuti, Diego Martines, Attilio Cecchetto, Silvia Chiarelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11866313     DOI： 10.1111/j.1572-0241.2002.05521.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  9 in total

1.  Correlation between histopathological findings of the liver and IgA class antibodies to 2-oxo-acid dehydrogenase complex in primary biliary cirrhosis.

Authors:  Jun-Ichi Masuda; Katsuhisa Omagari; Kazuo Ohba; Hiroaki Hazama; Yoshiko Kadokawa; Hideki Kinoshita; Kenji Hayashida; Kazuhiro Hayashida; Hiromi Ishibashi; Yasuni Nakanuma; Shigeru Kohno
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

Review 2.  Primary biliary cholangitis: pathogenesis and therapeutic opportunities.

Authors:  Aliya F Gulamhusein; Gideon M Hirschfield
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-12-09       Impact factor: 46.802

Review 3.  Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics.

Authors:  Ji-Won Park; Jung-Hee Kim; Sung-Eun Kim; Jang Han Jung; Myoung-Kuk Jang; Sang-Hoon Park; Myung-Seok Lee; Hyoung-Su Kim; Ki Tae Suk; Dong Joon Kim
Journal:  Biomedicines       Date:  2022-05-31

Review 4.  Increased Intestinal Permeability and Decreased Barrier Function: Does It Really Influence the Risk of Inflammation?

Authors:  Hiroshi Fukui
Journal:  Inflamm Intest Dis       Date:  2016-07-20

Review 5.  Galectin-3 in Inflammasome Activation and Primary Biliary Cholangitis Development.

Authors:  Aleksandar Arsenijevic; Bojana Stojanovic; Jelena Milovanovic; Dragana Arsenijevic; Nebojsa Arsenijevic; Marija Milovanovic
Journal:  Int J Mol Sci       Date:  2020-07-19       Impact factor: 5.923

6.  Macrophage Activation Markers Predict Liver-Related Complications in Primary Biliary Cholangitis.

Authors:  Yukihisa Fujinaga; Tadashi Namisaki; Yuki Tsuji; Junya Suzuki; Koji Murata; Soichi Takeda; Hiroaki Takaya; Takashi Inoue; Ryuichi Noguchi; Yuki Fujimoto; Masahide Enomoto; Norihisa Nishimura; Koh Kitagawa; Kosuke Kaji; Hideto Kawaratani; Takemi Akahane; Akira Mitoro; Hitoshi Yoshiji
Journal:  Int J Mol Sci       Date:  2022-08-29       Impact factor: 6.208

Review 7.  Intestinal homeostasis in autoimmune liver diseases.

Authors:  Qiaoyan Liu; Wei He; Ruqi Tang; Xiong Ma
Journal:  Chin Med J (Engl)       Date:  2022-07-20       Impact factor: 6.133

8.  Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis.

Authors:  Stella Gabeta; Gary L Norman; Christos Liaskos; Panagiotis A Papamichalis; Theodoros Zografos; Athanasios Garagounis; Eirini I Rigopoulou; George N Dalekos
Journal:  J Clin Immunol       Date:  2007-05-21       Impact factor: 8.542

Review 9.  The Role of Gut-Derived Microbial Antigens on Liver Fibrosis Initiation and Progression.

Authors:  Dishen Chen; Thanh H Le; Haleh Shahidipour; Scott A Read; Golo Ahlenstiel
Journal:  Cells       Date:  2019-10-27       Impact factor: 6.600
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.